JP2024000504A5 - - Google Patents
Info
- Publication number
- JP2024000504A5 JP2024000504A5 JP2023083544A JP2023083544A JP2024000504A5 JP 2024000504 A5 JP2024000504 A5 JP 2024000504A5 JP 2023083544 A JP2023083544 A JP 2023083544A JP 2023083544 A JP2023083544 A JP 2023083544A JP 2024000504 A5 JP2024000504 A5 JP 2024000504A5
- Authority
- JP
- Japan
- Prior art keywords
- hsa
- mir
- hmgb1
- hmgb1 expression
- expression inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/877,773 US20250382614A1 (en) | 2022-06-20 | 2023-06-12 | Hmgb1 expression regulator, prophylactic agent or therapeutic agent for acute lung injury, acute respiratory distress syndrome, or sepsis, or method of ameliorating same |
| CN202380046684.6A CN119365204A (zh) | 2022-06-20 | 2023-06-12 | Hmgb1的表达调控剂;急性肺损伤、急性呼吸窘迫综合征或败血症的预防药或治疗药,或它们的改善方法 |
| PCT/JP2023/021640 WO2023248844A1 (ja) | 2022-06-20 | 2023-06-12 | Hmgb1の発現制御剤;急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 |
| EP23827030.0A EP4541358A1 (en) | 2022-06-20 | 2023-06-12 | Hmgb1 expression suppressor, prophylactic or therapeutic drug for acute lung injury, acute respiratory distress syndrome or sepsis, and method for ameliorating such disease |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022098639 | 2022-06-20 | ||
| JP2022098639 | 2022-06-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024000504A JP2024000504A (ja) | 2024-01-05 |
| JP2024000504A5 true JP2024000504A5 (cg-RX-API-DMAC7.html) | 2026-05-27 |
Family
ID=89384628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023083544A Pending JP2024000504A (ja) | 2022-06-20 | 2023-05-20 | Hmgb1の発現制御剤;急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 |
| JP2023083545A Pending JP2024000505A (ja) | 2022-06-20 | 2023-05-20 | Ptx3の発現制御剤;関節リウマチ、自己免疫疾患に伴う血管炎または皮膚硬化の予防薬または治療薬、あるいはそれらの改善方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023083545A Pending JP2024000505A (ja) | 2022-06-20 | 2023-05-20 | Ptx3の発現制御剤;関節リウマチ、自己免疫疾患に伴う血管炎または皮膚硬化の予防薬または治療薬、あるいはそれらの改善方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP2024000504A (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025170079A1 (ja) * | 2024-02-09 | 2025-08-14 | セルファクター株式会社 | 慢性炎症を抑制するための医薬組成物 |
| WO2025181030A1 (en) * | 2024-02-26 | 2025-09-04 | Fundació Institut D'investigació I Innovació Parc Taulí | Therapy for inflammatory lung diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014126176A1 (ja) * | 2013-02-13 | 2014-08-21 | 国立大学法人名古屋大学 | 炎症性疾患の予防又は治療用組成物 |
-
2023
- 2023-05-20 JP JP2023083544A patent/JP2024000504A/ja active Pending
- 2023-05-20 JP JP2023083545A patent/JP2024000505A/ja active Pending